The prognostic value of DNA ploidy was evaluated in 25 patients with primary gastric leiomyosarcoma, using parafin-embedded archival specimens analysed by DNA $ow cytometry. Ploidy patterns were diploid in ten tumours and non-diploid in 15. They did not correlate with clinicopathological features of
β¦ LIBER β¦
The prognostic value of p53 and DNA ploidy following radical prostatectomy
β Scribed by C. Deliveliotis; A. Skolarikos; A. Karayannis; V. Tzelepis; N. Trakas; E. Alargof; V. Protogerou
- Publisher
- Springer-Verlag
- Year
- 2003
- Tongue
- English
- Weight
- 230 KB
- Volume
- 21
- Category
- Article
- ISSN
- 0724-4983
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Prognostic value of DNA ploidy in primar
β
Professor H. Suzuki; N. Sugihira
π
Article
π
1993
π
John Wiley and Sons
π
English
β 224 KB
π 2 views
Prognostic value of telomerase and DNA p
β
Talaat Samny; Hisham Halaby; Lobna Fiky; Mohamed Nassar; Ali Makhzangy; Sannaa E
π
Article
π
2005
π
Springer-Verlag
π
English
β 204 KB
Multivariable analysis of DNA ploidy, p5
Multivariable analysis of DNA ploidy, p53, and HER-2/neu as prognostic factors in endometrial cancer
β
Andrea S. Lukes; Matthew F. Kohler; Carl F. Pieper; Billie J. Kerns; Rex Bentley
π
Article
π
1994
π
John Wiley and Sons
π
English
β 554 KB
Node negative breast cancer: The prognos
β
J. Yuan; C. Hennessy; I. P. Corbett; R. Dykin; A. L. Givan; B. K. Shenton; J. A.
π
Article
π
1991
π
John Wiley and Sons
π
English
β 458 KB
π 2 views
Diagnostic and prognostic value of dna p
β
Cinzia Melchiorri; Luigi Bolondi; Pasquale Chieco; Maura Pagnoni; Laura Gramanti
π
Article
π
1994
π
John Wiley and Sons
π
English
β 648 KB
Prognostic value of Her-2/neu and DNA in
β
Sumit Isharwal; Michael Craig Miller; Jonathan I. Epstein; Leslie A. Mangold; El
π
Article
π
2008
π
John Wiley and Sons
π
French
β 300 KB
## Abstract Abnormal DNA content in tumor cells represents large scale chromosomal alterations and reflects later changes of genetic instability. __Herβ2/neu__ oncogene is amplified in 20β30% of breast and ovarian cancer patients and is associated with poor prognosis. Therefore, we evaluated progno